SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013159
Filing Date
2022-05-13
Accepted
2022-05-13 06:35:33
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 728055
2 ex31-1.htm EX-31.1 18958
3 ex31-2.htm EX-31.2 18937
4 ex32-1.htm EX-32.1 10730
  Complete submission text file 0001493152-22-013159.txt   3681265

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptix-20220331.xsd EX-101.SCH 30982
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptix-20220331_cal.xml EX-101.CAL 41330
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptix-20220331_def.xml EX-101.DEF 146326
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptix-20220331_lab.xml EX-101.LAB 279696
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptix-20220331_pre.xml EX-101.PRE 214138
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 450518
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 22920173
SIC: 7389 Services-Business Services, NEC